We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Saniona AB’s Nomination Committee for the Annual General Meeting 2023 PRESS RELEASE November 25, 2022 Saniona (OMX: SANION), a clinical stage biopharmaceutical company, today announced the...
Saniona publishes its interim report for the third quarter of 2022 Three Months Ended September 30, 2022 (2021)Nine Months Ended September 30, 2022 (2021)Revenue was SEK 2.4 M (2.3...
Saniona’s anti-inflammatory and anti-fibrotic candidate SAN903 is ready for clinical studies PRESS RELEASE November 3, 2022 SAN903 has finalized preclinical development and fulfilled other...
Saniona extends runway and amends loan agreement with Formue Nord PRESS RELEASE September 30, 2022 Saniona (OMX: SANION), a clinical stage biopharmaceutical company, today announced that...
Saniona publishes its interim report for the second quarter of 2022 Three Months Ended June 30, 2022 (2021)Six Months Ended June 30, 2022 (2021)Revenue was SEK 3.0 M (1.9 M)Revenue was SEK...
Bulletin from the Saniona AB extraordinary general meeting on August 18, 2022 PRESS RELEASE August 18, 2022 Today, on August 18, 2022, an extraordinary general meeting was held in Saniona...
Saniona progresses its Kv7 epilepsy program into Lead Optimization PRESS RELEASE August 16, 2022 Saniona (OMX: SANION), a clinical stage biopharmaceutical company, today announced that it...
Saniona provides update on outstanding option programs PRESS RELEASE August 5, 2022 Saniona (OMX: SANION), a clinical stage biopharmaceutical company, today announced that 6,450,734 options...
Notice of extraordinary general meeting in Saniona AB PRESS RELEASE 15 July 2022 The English text is an unofficial translation. In case of any discrepancies between the Swedish text and the...
Saniona CEO Thomas Feldthus and board member Carl Johan Sundberg purchase Saniona shares in the open market PRESS RELEASE July 6, 2022 Saniona (OMX: SANION), a clinical stage...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 33.35 | 33.35 | 33.35 | 4155 | 33.35 | DE |
4 | 0 | 0 | 33.35 | 33.35 | 33.35 | 3716 | 33.35 | DE |
12 | 0 | 0 | 33.35 | 33.35 | 33.35 | 2009 | 33.35 | DE |
26 | 0 | 0 | 33.35 | 33.35 | 33.35 | 1142 | 33.35 | DE |
52 | 0 | 0 | 33.35 | 33.35 | 33.35 | 1736 | 33.35 | DE |
156 | 0 | 0 | 33.35 | 33.35 | 33.35 | 2822 | 33.35 | DE |
260 | 0 | 0 | 33.35 | 33.35 | 33.35 | 2553 | 33.35 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions